Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Gene Found that Regulates Mold’s Resistance to Drugs

By Drug Discovery Trends Editor | November 10, 2008

Montana State University scientists concerned about lethal mold infections have found a gene that regulates the mold’s resistance to drugs.

The gene, called srbA, allows molds to thrive during infections even when inflammation reduces its oxygen supply, said Robert Cramer, senior author of a paper published in the Nov. 7 issue of PloS Pathogens. When the gene is removed, the mold becomes much more vulnerable to lack of oxygen and can no longer grow to cause disease.

The gene is found in humans and molds, but the researchers studied it in a common mold called Aspergillus fumigatus, said Cramer, assistant professor of fungal pathogenesis in MSU’s Department of Veterinary Molecular Biology. A. fumigatus can invade the lungs and cause dangerous diseases, including Invasive Pulmonary Aspergillosis. Patients with compromised immune systems, especially organ transplant patients, are particularly at risk.

‘The incidence of potentially lethal infections caused by normally benign molds has increased tremendously over the last two decades,’ the researchers wrote.

The scientists discovered the value of srbA after creating a mutant version of the fungus without the gene, Cramer said. Tests showed that the loss of srbA affected 87 genes in the fungus. Without the gene, the mutant could no longer grow when oxygen was limited, which occurs during mold infections. The mutant mold without srbA could no longer cause disease. It was also highly susceptible to antifungal drugs, more vulnerable than the original, complete mold.

Further study showed that srbA plays a critical role in the making of ergosterol, the fungal-form of cholesterol, Cramer said. The gene in humans is associated with the making of cholesterol. Ergosterol and cholesterol are necessary components of cell membranes.

‘The reason we’re interested is because ergosterol is a target for most of the antifungal drugs that are available,’ Cramer said. ‘These drugs target the synthesis of ergosterol. … If you get rid of ergosterol, you kill the mold.’

Sven Willger, a postdoctoral researcher in Cramer’s lab and first author of the PLoS Pathogens paper, said the absence of srbA changed the way the mold cells grew. Instead of growing from the tip, they branched off from several other locations. The confusion became apparent under a transmission electron microscope.

The researchers said in their paper that they demonstrated the significance of invasive molds adapting to reduced oxygen levels during infection.

Release Date: November 6, 2008
Source: Montana State University 


Filed Under: Genomics/Proteomics

 

Related Articles Read More >

Spatial biology: Transforming our understanding of cellular environments
DNA double helix transforming into bar graphs, blue and gold, crisp focus on each strand, scientific finance theme --ar 5:4 --personalize 3kebfev --v 6.1 Job ID: f40101e1-2e2f-4f40-8d57-2144add82b53
Biotech in 2025: Precision medicine, smarter investments, and more emphasis on RWD in clinical trials
DNA helix 3D illustration. Mutations under microscope. Decoding genome. Virtual modeling of chemical processes. Hi-tech in medicine
Genomics in 2025: How $500 whole genome sequencing could democratize genomic data
A media release and Scientific Report image of Elizabeth Kellogg. - Camera Settings: ILCE-9M2, 12mm, ISO 1000, 1/80, f/3.2, Fri, 04-19-2024 at 10:10. v.12.01.23
St. Jude pioneers gene editing and structural biology to advance pediatric research
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE